Literature DB >> 15071046

Detection of the Escherichia coli group 2 polysaccharide capsule synthesis Gene kpsM by a rapid and specific PCR-based assay.

James R Johnson1, Timothy T O'Bryan.   

Abstract

A rapid and simple PCR-based assay for detection of the group 2 capsule synthesis gene kpsM of Escherichia coli was designed and validated. When combined with the published group 2 primers (kpsIIf, 5'-GCGCATTTGCTGATACTGTTG-3'; kpsIIr, 5'-CATCCAGACGATAAGCATGAGCA-3'), the new primers (the kpsIIf primer and a new reverse primer K2r, 5'-AGGTAGTTCAGACTCACACCT-3') allowed specific identification by exclusion of the heretofore elusive K2 kpsM variant. The primers yielded the predicted amplicon when multiplexed with other primers and used under varied assay conditions, including a range of concentrations of individual reaction mixture ingredients and of annealing temperatures (from 54 to 64 degrees C).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071046      PMCID: PMC387594          DOI: 10.1128/JCM.42.4.1773-1776.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  Loss of resistance to ingestion and phagocytic killing by O(-) and K(-) mutants of a uropathogenic Escherichia coli O75:K5 strain.

Authors:  S M Burns; S I Hull
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 2.  Development of polymerase chain reaction-based assays for bacterial gene detection.

Authors:  J R Johnson
Journal:  J Microbiol Methods       Date:  2000-08       Impact factor: 2.363

3.  Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens.

Authors:  C Le Bouguénec; L Lalioui; L du Merle; M Jouve; P Courcoux; S Bouzari; R Selvarangan; B J Nowicki; Y Germani; A Andremont; P Gounon; M I Garcia
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Authors:  R A Welch; V Burland; G Plunkett; P Redford; P Roesch; D Rasko; E L Buckles; S-R Liou; A Boutin; J Hackett; D Stroud; G F Mayhew; D J Rose; S Zhou; D C Schwartz; N T Perna; H L T Mobley; M S Donnenberg; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-05       Impact factor: 11.205

5.  Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli.

Authors:  J R Johnson; P Delavari; M Kuskowski; A L Stell
Journal:  J Infect Dis       Date:  2000-11-22       Impact factor: 5.226

6.  Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli).

Authors:  Richard J Bauer; Lixin Zhang; Betsy Foxman; Anja Siitonen; Maria E Jantunen; Harri Saxen; Carl F Marrs
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

7.  Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.

Authors:  J R Johnson; T T O'Bryan; M Kuskowski; J N Maslow
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Haemolytic Escherichia coli isolated from dogs with diarrhea have characteristics of both uropathogenic and necrotoxigenic strains.

Authors:  Marjanca Starcic; James R Johnson; Adam L Stell; Jeanet van der Goot; Henno G C J M Hendriks; Camillo van Vorstenbosch; Linda van Dijk; Wim Gaastra
Journal:  Vet Microbiol       Date:  2002-04-02       Impact factor: 3.293

9.  Canine feces as a reservoir of extraintestinal pathogenic Escherichia coli.

Authors:  J R Johnson; A L Stell; P Delavari
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

10.  Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products.

Authors:  James R Johnson; Andrew C Murray; Abby Gajewski; Maureen Sullivan; Paula Snippes; Michael A Kuskowski; Kirk E Smith
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more
  14 in total

1.  Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.

Authors:  James R Johnson; Stephen B Porter; George Zhanel; Michael A Kuskowski; Erick Denamur
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

2.  Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide.

Authors:  Jaione Valle; Sandra Da Re; Nelly Henry; Thierry Fontaine; Damien Balestrino; Patricia Latour-Lambert; Jean-Marc Ghigo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

3.  Role of the vpe carbohydrate permease in Escherichia coli urovirulence and fitness in vivo.

Authors:  Vanessa Martinez-Jéhanne; Christophe Pichon; Laurence du Merle; Olivier Poupel; Nadège Cayet; Christiane Bouchier; Chantal Le Bouguénec
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

4.  Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.

Authors:  Bente Olesen; Dennis S Hansen; Frida Nilsson; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Flemming Scheutz; Brian Johnston; Karen A Krogfelt; James R Johnson
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

5.  Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.

Authors:  Bente Olesen; Jakob Frimodt-Møller; Rikke Fleron Leihof; Carsten Struve; Brian Johnston; Dennis S Hansen; Flemming Scheutz; Karen A Krogfelt; Michael A Kuskowski; Connie Clabots; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

6.  Population Structure and Antimicrobial Resistance of Canine Uropathogenic Escherichia coli.

Authors:  Tessa E LeCuyer; Barbara A Byrne; Joshua B Daniels; Dubraska V Diaz-Campos; G Kenitra Hammac; Claire B Miller; Thomas E Besser; Margaret A Davis
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

7.  Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus.

Authors:  Abdulaziz Alqasim; Fleming Scheutz; Zhiyong Zong; Alan McNally
Journal:  BMC Genomics       Date:  2014-09-30       Impact factor: 3.969

8.  Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India.

Authors:  Kesavaram Padmavathy; Krishnan Padma; Sikhamani Rajasekaran
Journal:  J Pathog       Date:  2016-03-30

9.  A Fatal Case of Necrotizing Fasciitis Caused by a Highly Virulent Escherichia coli Strain.

Authors:  Sadjia Bekal; André Vincent; Alex Lin; Josée Harel; Jean-Charles Côté; Cécile Tremblay
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-31       Impact factor: 2.471

10.  Diarrhea, bacteremia and multiorgan dysfunction due to an extraintestinal pathogenic Escherichia coli strain with enteropathogenic E. coli genes.

Authors:  Robert Kessler; Shahista Nisa; Tracy H Hazen; Amy Horneman; Anthony Amoroso; David A Rasko; Michael S Donnenberg
Journal:  Pathog Dis       Date:  2015-09-26       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.